SeekingAlpha · Aug 14, 2026
NASDAQ · AZTA
Azenta, Inc.
Healthcare · Medical - Instruments & Supplies
$35.62
Up+$2.64 (+8.00%)
Updated Aug 20, 2026, 1:26 PM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.72B
- P/E ratio
- -28.92
- Dividend yield
- 0.00%
- 52-week range
- $15.93 – $35.89
- Volume
- 839.91K
- Avg. volume
- 606.52K
Price performance
AZTA price history
1M range · 0 trading sessions · Daily adjusted prices
AZTA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest AZTA news
The latest Smart Investors Daily articles mentioning AZTA.
Stock researchCompany · Overview
AZTA research
Overview
Company profile and research snapshot.
Company profile
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $38.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 5, 2026 | Needham | Buy | — |
| May 6, 2026 | Needham | Buy | — |
| Apr 6, 2026 | Evercore ISI Group | Outperform | — |
| Mar 17, 2026 | Needham | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 6, 2026
Evercore ISI Group Maintains Outperform on Azenta, Raises Price Target to $35
Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:AZTA) with a Outperform and raises the price target from $28 to $35.
Benzinga · Aug 5, 2026
Needham Maintains Buy on Azenta, Raises Price Target to $37
Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and raises the price target from $33 to $37.
SeekingAlpha · Aug 5, 2026
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q3 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsYvonne Perron - Vice President of Financial Planning & Analysis...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
